Ferring Pharmaceuticals
Clinical trials sponsored by Ferring Pharmaceuticals, explained in plain language.
-
New fertility drug tested against standard in chinese IVF study
Disease control CompletedThis study tested two different fertility medicines (follitropin delta and follitropin alfa) to see which works better for stimulating ovaries to produce eggs for IVF. 301 Chinese women aged 20-40 took part. The main goal was to count how many eggs were retrieved after treatment.
Phase: PHASE3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Prostate cancer drug degarelix safe over 5 years in extension trial
Disease control CompletedThis study checked the long-term safety of the drug degarelix in men with prostate cancer. Participants had already completed an earlier study and continued treatment for up to 5 years. The main goal was to see if any serious side effects occurred over time.
Phase: PHASE2, PHASE3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
Colonoscopy delivery of RBX2660 shows promise for recurrent c. diff
Disease control CompletedThis study tested whether RBX2660 (REBYOTA), a treatment for recurrent Clostridioides difficile infection, can be safely and effectively given via colonoscopy instead of the usual method. 41 adults with at least one recurrence of C. diff took part. The main goals were to check fo…
Phase: PHASE3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 11:58 UTC
-
New treatment shows promise in stopping dangerous gut infection from coming back
Prevention CompletedThis study looked at how well a treatment called REBYOTA works in real-world clinics to stop Clostridioides difficile infection (C. diff) from coming back. Researchers followed 145 adults who had already finished antibiotics for a C. diff infection and were given REBYOTA to preve…
Sponsor: Ferring Pharmaceuticals • Aim: Prevention
Last updated May 26, 2026 11:59 UTC
-
Massive study reviews NOCDURNA safety in over 1 million patients
Knowledge-focused CompletedThis study looked at medical records from Denmark, Sweden, and Germany to check the safety of NOCDURNA, a drug for frequent nighttime urination caused by nocturnal polyuria. Researchers tracked over 1 million adults to see how often serious side effects like low sodium levels occ…
Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 12:11 UTC
-
New study tracks Real-World use of fertility drug REKOVELLE®
Knowledge-focused CompletedThis study looked at how doctors prescribe REKOVELLE®, a fertility medicine, for women going through their first IVF or ICSI treatment. Researchers observed 201 women across clinics in Nordic countries and Switzerland to see how the drug's dosing algorithm works in everyday pract…
Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 11:09 UTC